| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 |
| Total Revenue | 911 | 682 | 793 | 796 |
| Cost of Revenue | 303 | 185 | 178 | 430 |
|
| Gross Profit | 607 | 497 | 614 | 366 |
|
| Operating Expenses |
| Research Development | 145 | 153 | 139 | 186 |
| Selling General and Administrative | 447 | 395 | 335 | 607 |
| Non Recurring |
-
|
-
|
-
|
-
|
| Others |
-
|
-
|
-
|
-
|
| |
| Total Operating Expenses |
-
|
-
|
-
|
-
|
|
|
| Operating Income or Loss | 14 | (51) | 140 | (427) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | 13 | 13 | 12 |
-
|
| Earnings Before Interest And Taxes | 27 | (38) | 152 | (427) |
| Interest Expense | 2 | 3 |
-
| 59 |
| Income Before Tax | 25 | (41) | 152 | (485) |
| Income Tax Expense |
-
|
-
|
-
|
-
|
| Minority Interest |
-
|
-
|
-
|
-
|
| |
| Net Income From Continuing Ops | 63 | (41) | 152 | (485) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
| Net Income | 25 | (41) | 152 | (485) |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares | $25 | ($41) | $152 | ($485) |
0.01% Nasdaq 
Income Statement
